Drugs used in the treatment of obesity: literature review
DOI:
https://doi.org/10.37497/ijhmreview.v7i3.277Keywords:
Obesity, Pharmacotherapy, On Label Use, Off Label UseAbstract
Obesity is a disease with a multifactorial cause with high incidence and prevalence today in the world. According to the World Health Organization (WTO), obesity is characterized by excessive accumulation of fat and its diagnosis is made mainly through the use of the Body Mass Index (BMI) whose calculation is performed by the divided mass by height squared. BMI values above 30 generally mean that the individual is somewhat obese. However, it is necessary to evaluate with criteria, since the BMI does not differentiate the muscle from the fat, thus being very important to evaluate the corporal distribution. Data published by the Ministry of Health in April 2017 show that 1 in 5 people in Brazil are overweight, which demonstrates that this disease has already acquired a high relevance in the country. It is known that obesity in many cases is associated with hypertension, diabetes, dyslipidemia and insulin resistance, a condition called Metabolic Syndrome. Thus, the treatment of obese patients in order to reduce their fat mass is necessary to prevent diseases caused by these metabolic changes, such as acute myocardial infarction and stroke. In addition to lifestyle changes, the use of medications for the treatment of obese patients is extremely important, therefore, this study aims to review the medications used in the pharmacotherapy of obese patients.
Downloads
How to Cite
Issue
Section
License
Authors who publish in this journal agree to the following terms: The author(s) authorize the publication of the text in the journal; The author(s) guarantee that the contribution is original and unpublished and is not in the process of being evaluated by any other journal(s); The journal is not responsible for the opinions, ideas, and concepts contained in the texts, as these are the sole responsibility of their respective author(s); The editors reserve the right to make adjustments to the text in order to ensure that it adheres to the standards of the journal. Authors retain the copyrights and grant the journal the right of first publication, with the article simultaneously licensed under the Creative Commons Attribution License which allows the sharing of the article with the acknowledgment of authorship and initial publication in this journal. Authors are authorized to take additional contracts separately, for the non-exclusive distribution of the version of the article published in this journal (e.g. publication in an institutional repository or as a book chapter), with the acknowledgment of authorship and initial publication in this journal.
Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal webpage) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and citation of published work (See The Effect of Free Access at http://opcit.eprints.org/oacitation-biblio.html)
